Institutional Investor T. Rowe Price Holds 2.21M Shares of MOH (4.1%)

Rhea-AI Filing Summary

T. Rowe Price Associates reported a beneficial ownership stake in Molina Healthcare Inc. totaling 2,207,124 shares, equal to 4.1% of the outstanding common stock. The filing shows the firm has sole voting power over 2,124,376 shares and sole dispositive power over 2,206,422 shares, with no shared voting or dispositive power.

The filing is submitted on Schedule 13G and classifies the filer as an investment adviser. The filer certifies the shares were acquired and are held in the ordinary course of business and states the position was not taken to change or influence control of the issuer, and the filer disclaims beneficial ownership in one section.

Positive

• Institutional ownership: T. Rowe Price reports holding 2,207,124 shares (4.1%), indicating meaningful institutional interest in MOH

Negative

• None.

Insights

Securities Analyst

TL;DR: A 4.1% institutional stake is notable but remains below the 5% threshold that typically triggers greater scrutiny or activist signaling.

The reported 2.21 million-share position by a major asset manager signals routine portfolio ownership rather than a control intent. The breakdown showing almost identical dispositive power and aggregate holdings suggests centralized trading and custody arrangements typical for investment advisers. Because the filing is a Schedule 13G and the filer affirms ordinary-course investment intent, the short-term market impact is likely limited and disclosure primarily increases transparency for investors monitoring institutional ownership.

Corporate Governance Expert

TL;DR: Ownership structure indicates passive institutional ownership with no shared control, reducing immediate governance implications.

The filer reports sole voting power over 2,124,376 shares and no shared voting power, which means voting authority rests with T. Rowe Price for that portion of the stake. However, the overall 4.1% position and the Schedule 13G designation reflect a passive holding; the certification that the stake is not for influencing control further reduces governance concern. Investors should note disclosure improves visibility but does not signal a governance campaign.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MOLINA HEALTHCARE INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

60855R100

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 60855R100

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,124,376.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,206,422.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,207,124.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MOLINA HEALTHCARE INC
(b)	Address of issuer's principal executive offices: 200 OCEANGATE, SUITE 100, LONG BEACH, CA, 90802
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 60855R100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2207124
(b)	Percent of class: 4.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2124376
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2206422
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	08/14/2025

FAQ

How many MOH shares does T. Rowe Price report owning?

T. Rowe Price reports beneficial ownership of 2,207,124 shares of Molina Healthcare common stock.

What percentage of Molina Healthcare (MOH) does T. Rowe Price own?

The filing states a 4.1% ownership stake in the class of common stock.

How much voting and dispositive power does T. Rowe Price report for MOH shares?

The filer reports sole voting power over 2,124,376 shares, sole dispositive power over 2,206,422 shares, and no shared voting or dispositive power.

Is T. Rowe Price claiming the stake is intended to influence control of MOH?

No. The filer certifies the securities are held in the ordinary course of business and were not acquired to change or influence control.

Under what reporting classification was this ownership disclosed?

The position was disclosed on Schedule 13G with the reporting person classified as an investment adviser (IA), consistent with passive institutional disclosure.